These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 22525084)
1. Absorption-promoting effects of chitosan in airway and intestinal cell lines: a comparative study. Vllasaliu D; Casettari L; Fowler R; Exposito-Harris R; Garnett M; Illum L; Stolnik S Int J Pharm; 2012 Jul; 430(1-2):151-60. PubMed ID: 22525084 [TBL] [Abstract][Full Text] [Related]
2. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells. Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606 [TBL] [Abstract][Full Text] [Related]
3. Barrier characteristics of epithelial cultures modelling the airway and intestinal mucosa: a comparison. Vllasaliu D; Fowler R; Garnett M; Eaton M; Stolnik S Biochem Biophys Res Commun; 2011 Dec; 415(4):579-85. PubMed ID: 22079636 [TBL] [Abstract][Full Text] [Related]
4. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions. Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157 [TBL] [Abstract][Full Text] [Related]
5. Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis. De Walle JV; Sergent T; Piront N; Toussaint O; Schneider YJ; Larondelle Y Toxicol Appl Pharmacol; 2010 Jun; 245(3):291-8. PubMed ID: 20362602 [TBL] [Abstract][Full Text] [Related]
6. Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells. Duizer E; van der Wulp C; Versantvoort CH; Groten JP J Pharmacol Exp Ther; 1998 Oct; 287(1):395-402. PubMed ID: 9765361 [TBL] [Abstract][Full Text] [Related]
7. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. Grenha A; Grainger CI; Dailey LA; Seijo B; Martin GP; Remuñán-López C; Forbes B Eur J Pharm Sci; 2007 Jun; 31(2):73-84. PubMed ID: 17408932 [TBL] [Abstract][Full Text] [Related]
9. Effect of N-betainate and N-piperazine derivatives of chitosan on the paracellular transport of mannitol in Caco-2 cells. Korjamo T; Holappa J; Taimisto S; Savolainen J; Järvinen T; Mönkkönen J Eur J Pharm Sci; 2008 Oct; 35(3):226-34. PubMed ID: 18675903 [TBL] [Abstract][Full Text] [Related]
10. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138 [TBL] [Abstract][Full Text] [Related]
11. Effect of PEGylation on the toxicity and permeability enhancement of chitosan. Casettari L; Vllasaliu D; Mantovani G; Howdle SM; Stolnik S; Illum L Biomacromolecules; 2010 Nov; 11(11):2854-65. PubMed ID: 20873757 [TBL] [Abstract][Full Text] [Related]
12. Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A Int J Pharm; 2008 Jul; 359(1-2):70-8. PubMed ID: 18450395 [TBL] [Abstract][Full Text] [Related]
13. Chitosan enhances transcellular permeability in human and rat intestine epithelium. Canali MM; Pedrotti LP; Balsinde J; Ibarra C; Correa SG Eur J Pharm Biopharm; 2012 Feb; 80(2):418-25. PubMed ID: 22119733 [TBL] [Abstract][Full Text] [Related]
14. The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier. Rosenthal R; Günzel D; Finger C; Krug SM; Richter JF; Schulzke JD; Fromm M; Amasheh S Biomaterials; 2012 Mar; 33(9):2791-800. PubMed ID: 22230222 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. Rekha MR; Sharma CP J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862 [TBL] [Abstract][Full Text] [Related]
16. Effect of chitosan glutamate, carbomer 974P, and EDTA on the in vitro Caco-2 permeability and oral pharmacokinetic profile of acyclovir in rats. Merzlikine A; Rotter C; Rago B; Poe J; Christoffersen C; Thomas VH; Troutman M; El-Kattan A Drug Dev Ind Pharm; 2009 Sep; 35(9):1082-91. PubMed ID: 19294548 [TBL] [Abstract][Full Text] [Related]
17. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers. Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2). Kotzé AF; Thanou MM; Luebetaen HL; de Boer AG; Verhoef JC; Junginger HE J Pharm Sci; 1999 Feb; 88(2):253-7. PubMed ID: 9950647 [TBL] [Abstract][Full Text] [Related]
19. Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan. Hsu LW; Lee PL; Chen CT; Mi FL; Juang JH; Hwang SM; Ho YC; Sung HW Biomaterials; 2012 Sep; 33(26):6254-63. PubMed ID: 22681978 [TBL] [Abstract][Full Text] [Related]
20. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers. Maher S; Feighery L; Brayden DJ; McClean S Pharm Res; 2007 Jul; 24(7):1336-45. PubMed ID: 17373574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]